Indicated for: Multiple Myeloma (MM): In combination with Dexamethasone. Used in newly diagnosed patients and those who have received at least one prior therapy. Mantle Cell Lymphoma (MCL): For patients whose disease has relapsed or progressed.

Dosage and administration

Strength: 25 mg capsule. Standard Cycle (28 Days): 📅 Days 1-21: Take one 25 mg capsule once daily. 📅 Days 22-28: Rest period (no medication). ⚠️ ADMINISTRATION: 💊 Swallow whole with water. Teratogenic hazard: Do not open or break capsules. Renal Alert: If Creatinine Clearance is < 60 mL/min, the dose must be reduced to 10 mg.

At 25 mg, toxicity monitoring is crucial: Severe Neutropenia/Thrombocytopenia: Grade 3-4 hematologic toxicity is common. Weekly blood counts are required for the first 8 weeks. Venous Thromboembolism: High risk of clots. Antithrombotic prophylaxis is mandatory. Fatigue and Rash.

Lenalid 25 — Lenalidomide 25 mg, 30 pcs, Natco

100% original product

Active ingredient

Lenalidomide

Manufacturer

Natco

Dosage 25 mg

Dosage form Capsules

Capsules per pack 30

Lenalid 25 — Lenalidomide 25 mg

Name: Lenalid 25
Brand: Natco
SKU: PROD-27
Price: 7305 UAH
Availability: InStock

7305₴ ~~7747₴~~ -6%

Lenalid 25 mg is the highest strength capsule of the immunomodulator Lenalidomide.

Manufacturer: Natco Pharma (India). Generic equivalent of Revlimid.

Clinical Use:

This is the recommended starting dose for most patients with Multiple Myeloma who have normal renal function. It provides the maximum therapeutic effect to halt tumor progression and induce remission.

✅ Key Benefit: The gold standard for first-line and relapsed myeloma therapy.

Indicated for:

Multiple Myeloma (MM): In combination with Dexamethasone. Used in newly diagnosed patients and those who have received at least one prior therapy.
Mantle Cell Lymphoma (MCL): For patients whose disease has relapsed or progressed.

Strength: 25 mg capsule.

Standard Cycle (28 Days):

📅 Days 1-21: Take one 25 mg capsule once daily.
📅 Days 22-28: Rest period (no medication).

⚠️ ADMINISTRATION:

💊 Swallow whole with water. Teratogenic hazard: Do not open or break capsules.
Renal Alert: If Creatinine Clearance is < 60 mL/min, the dose must be reduced to 10 mg.

🚫 PREGNANCY WARNING (Category X):

Lenalidomide is structurally related to Thalidomide. It causes severe life-threatening birth defects. Strict pregnancy prevention programs must be followed by both men and women.

Also Contraindicated in:

Severe hypersensitivity to the drug.
Breastfeeding.

At 25 mg, toxicity monitoring is crucial:

Severe Neutropenia/Thrombocytopenia: Grade 3-4 hematologic toxicity is common. Weekly blood counts are required for the first 8 weeks.
Venous Thromboembolism: High risk of clots. Antithrombotic prophylaxis is mandatory.
Fatigue and Rash.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 18.03.2026